Although we observed a trend for aPS/PT in conferring an increased risk for TEs (crude HR 12.9, 95% CI 0.7–236.7; p = 0.08), the results failed to reach statistical significance.
← all excerpts
Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study.
1
—
—